We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Haleon plc (HLN) ADR Each Repr 2 Ord Shares SPON

Sell:$9.52 Buy:$9.64 Change: $0.07 (0.74%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Sell:$9.52
Buy:$9.64
Change: $0.07 (0.74%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Sell:$9.52
Buy:$9.64
Change: $0.07 (0.74%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Haleon plc is a consumer healthcare company. The Company's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

Contact details

Address:
Building 5, First Floor, The Heights
WEYBRIDGE
KT13 0NY
United Kingdom
Telephone:
+44 (1932) 822000
Website:
https://www.haleon.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
HLN
ISIN:
US4055521003
Market cap:
$42.32 billion
Shares in issue:
9.13 billion
Sector:
Personal Care Products
Exchange:
-
Country:
Great Britain
Currency:
US dollar
Indices:
n/a

Key personnel

  • Brian Mcnamara
    Chief Executive Officer, Executive Director
  • Dawn Allen
    Chief Financial Officer, Executive Director
  • Keith Choy
    President, Asia Pacific
  • Filippo Lanzi
    President, EMEA and LatAm
  • Lisa Paley
    President, North America
  • Line De Decker
    Chief Human Resource Officer
  • Tamara Rogers
    Chief Marketing Officer
  • Bjarne Tellmann
    General Counsel
  • Namrata Patel
    Chief Supply Chain Officer
  • Ed Petter
    Chief Corporate Affairs Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.